Atara to cut 50% of workforce amid FDA woes
Atara Biotherapeutics (ATRA) plans to cut around 50% of its workforce, just a little over a week after the FDA declined to ...
Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
The Aviationist on MSN6d
Airbus A320 ATRA Performs Maiden Flight After E-Scan AESA Radar Modification
The Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...
Atara Biotherapeutics, Inc. (ATRA) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Levi & Korsinsky notifies investors that it has commenced an investigation of Atara Biotherapeutics, Inc. ('Atara Biotherapeutics, Inc.') ...
GlobalData on MSN5d
Airbus’ A320 ATRA with Eurofighter nose completes first flight
Airbus has completion of a first flight for German Aerospace Center's (DLR) modified Airbus A320 ATRA for the E-Scan radar ...
FY2024 Earnings Estimate for ATRA Issued By HC Wainwright
HC Wainwright issued their FY2024 EPS estimates for Atara Biotherapeutics in a research note issued to investors on Wednesday, January 22nd. HC Wainwright analyst R. Burns forecasts that the ...
Jane's Information Group6d
Airbus flies ATRA test aircraft modified for Eurofighter E-Scan radar
Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...
Madison Pacific Properties Inc. announces Federal Court of Appeal judgement on tax reassessments appeal
Madison Pacific Properties Inc. (the Parent Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces judgement issued by the Federal Court of Appeal (“FCA”) on its tax ...
HC Wainwright Reiterates “Neutral” Rating for Atara Biotherapeutics (NASDAQ:ATRA)
Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report)‘s stock had its “neutral” rating reiterated by analysts at HC ...
Atara stock holds Neutral rating after workforce cut
H.C. Wainwright maintained its Neutral stance on Atara Biotherapeutics stock (NASDAQ:ATRA), following the company's announcement of a significant workforce reduction. According to InvestingPro data, ...